透過您的圖書館登入
IP:18.190.152.38
  • 期刊

R&D Effort, Effectiveness, and Firm Performance in the Pharmaceutical Sector

摘要


Research exploring the impact of R&D on firm outcomes yields mixed results. The paper draws on an integration of the resource-based view, the capabilities perspective, and accumulation theory to highlight the effectiveness of R&D effort in yielding recognized innovative output as a fundamental, yet underemphasized factor in the role of R&D as a contributor to firm performance. Specifically, innovative output is examined as an intervening factor in the relationship between R&D effort and firm performance. Empirical tests on a sample of 303 firms in the pharmaceutical industry reveal that R&D effort yields increasing returns to R&D effectiveness, which suggests that firms can enhance the value of research activities through increased activity. However, the discovery of innovative output as an important mediating factor between R&D effort and firm performance suggests that the benefit of increased R&D may be limited if this effort is not effective in yielding recognized innovative output. These findings are critical since managers in research-intensive industries often base resource allocation decisions on the assumed influence of R&D effort on firm performance.

關鍵字

無資料

延伸閱讀